Warning: file_exists(): open_basedir restriction in effect. File(/home/incindustrybymot/public_html/wp-content/themes/uncode-child/dynamic.css) is not within the allowed path(s): (/home/nimianet/:/tmp/:/var/tmp/:/opt/alt/php83/usr/share/pear/:/dev/urandom:/usr/local/php74/lib/:/usr/local/php83/lib/:/usr/local/php81/lib/:/usr/local/php74/lib/:/usr/local/php82/lib/:/usr/local/php73/lib/:/usr/local/lib/php/) in /home/nimianet/domains/test.nimia.net/public_html/wp-content/plugins/uncode-core/includes/theme-options/includes/ot-functions.php on line 277
FDA Approves First Drug for Peanut Allergy - International Nut & Dried Fruit Council
The drug, designed by biotech company Aimmune Therapeutics Inc., is an oral immunotherapy indicated for the mitigation of allergic reactions, that may occur with accidental exposure to peanut.
 
The treatment is approved in patients aged between 4-17 years old with a confirmed diagnosis of peanut allergy.

Join us

Sign up to become a member of the INC and discover the benefits of INC membership. Or subscribe and have access to our magazine, industry newsletters and industry directory.

Privacy Preference Center